Nutrino announces data partnership with Medtronic

June 10, 2016

NEW ORLEANS, June 10, 2016 - Today at the 76th Scientific Sessions of the American Diabetes Association, Nutrino, Inc. announced a partnership with Medtronic plc that will give people with diabetes an individualized picture of how daily food intake and other measures impact glucose levels. People who use Medtronic continuous glucose monitors (CGM) and insulin pumps in the United States will be able to connect them via MiniMed® Connect and CareLink® with the Nutrino app, a 24/7 nutrition companion, to get food suggestions and meal plans tailored to their carbohydrate intake, glucose levels and other measures.

"By working with Nutrino, we can have a real impact on the food decisions people with diabetes face every single day," said Annette Brüls, president of Global Diabetes Service and Solutions, Medtronic Diabetes. "With this new service, we will not only enhance our customers' day-to-day lives but will also help us collect insights to inform how we approach diabetes management in the future as we work to transform care to drive greater freedom and better health. In addition, the Nutrino diabetes-specific, validated food database and carb counting support will be available in Medtronic's digital offerings."

People living with Type 1 and Type 2 diabetes must manage their daily carbohydrate intake to keep glucose levels in check. Now, they will be able to download the Nutrino app and connect it with their CGM and insulin pump to get a picture of their FoodPrint™ - proprietary technology that shows how their daily food intake, activity, sleep and other parameters affect their glucose levels. In addition, the Nutrino app also connects with and draws data from multiple wellness devices and activity trackers such as Apple HealthKit, Runkeeper, Moves, Jawbone, Withings and Fitbit.

The app also allows people with diabetes to: "We are excited to partner with Medtronic to bring advanced nutrition insights to people living with diabetes," said Yael Glassman, president, Nutrino. "This is an important milestone for Nutrino as we take personalized, contextual and digital nutrition to the next level for the benefit of people living with chronic conditions."

According to the American Diabetes Association, more than 29 million Americans (9.3 percent of the population) are living with both type 1 and type 2 diabetes. Each year, 1.4 million Americans are newly diagnosed with diabetes and the disease remains the seventh-leading cause of death in the United States.

The beta App is available in the U.S., free of charge, for a limited time. People who use MiniMed Connect or have their CGM data in Apple HealthKit can benefit from the special diabetes features in Nutrino. To download the Nutrino beta app for diabetes, please visit

Nutrino is intended to help you understand your individual response to certain foods so that you can maintain a healthy diet. It should not be used as a basis for insulin dosing decisions or for trending and tracking of continuous glucose monitoring device (CGM) data. It does not provide current, real-time glucose information. For specific review of CGM data, only the CGM device itself or the CGM manufacturer's supporting software should be used.

About Nutrino

We're all different. But until now, the field of nutrition didn't acknowledge that simple fact. Why "until now"? Because now there's Nutrino. Nutrino scientifically determines the best foods for you as an individual. It takes into account your lifestyle, your health goals, your food preferences and eating habits, everything that makes you, you. It pulls in data collected by wearables and select medical devices to get to know you even better. Then it takes all this information to devise the best food choices for you. Nutrino even helps you make whatever changes you have to make to put these suggestions into effect. For more, visit

MiniMed® and CareLink® are registered trademarks of Medtronic plc.

Nutrino, Inc.

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to